NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/11/2023
Back to search
Official data from USPTO
OBIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
13
Latest update
07/11/2023
Trademark type
Combined
Nice classes
42
Filing date
05/26/2022
Registration date
07/11/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/11/2023
Last transaction
07/11/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
05/31/2019
First use in commerce
05/31/2019
Drawing code
5
Owner type
99
Owner location
Shanghai, CN
Examiner
YE, CINDY K
Law office
N80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the literal element "OBIO" in stylized font.
Holders and representatives
Holders
OBiO Technology ( Shanghai ) Corp., Ltd.
Representatives
NAZLY AILEEN BAYRAMOGLU BAYRAMOGLU LAW OFFICES LLC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Provision of technical information in the field of gene and cell therapylaboratory scientific research services being vector designviral packaging and functional genomics research services for academic researchers and gene therapy developers at pre-clinical stage; Providing information in the field of shortening and optimizing research and development times for researchers; Testinginspectionresearchdevelopment of pharmaceutical preparations for gene and cell therapy; providing laboratory research services in the field of gene functional researchdrug efficacy research or early development of genetic drugs; product quality testing services for gene therapy products; quality management servicesquality evaluation and analysisquality assurancequality control in the field of cell and gene therapy; Development of new technology for others in the field of genomicsbiotechnology
Publications
History of USPTO decisions and trademark events.
13 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/11/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/25/2023
PUBO
PUBLISHED FOR OPPOSITION
04/25/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/05/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/21/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
03/21/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/21/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
03/21/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/21/2023
DOCK
ASSIGNED TO EXAMINER
03/14/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/02/2022
NWAP
NEW APPLICATION ENTERED
05/30/2022
Continuous trademark protection
Get notified about every new filing that threatens OBIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.